AdaptVac

AdaptVac is a joint venture between ExpreS2ion Biotech and NextGen Vaccines, a spin-off from the University of Copenhagen, aimed at accelerating the development of safe and effective therapeutic and preventive vaccines for treating and preventing specific cancers, infectious diseases, and immune disorders.